Chemed Corporation (NYSE:CHE) reported on Friday that Q1 net income of $20.4 million, surged 13% from the similar quarter a year before, as its two operating units announced mixed results.
The downtown-based firm (NYSE:CHE) had non-GAAP earnings of $1.17 a share. That was below analyst anticipations of $1.25 per share, as posted by S&P Capital IQ.
Net patient revenue for Vitas Healthcare Corp., the company’s hospice unit, was $261 million, an moved up of nearly 11% over the quarter previous-year. The firm’s Roto-Rooter examining and drain-cleaning business had revenue of $92 million, a declared of 3%.
Sector analysis, over all tech sector moved up, Pfizer Inc. (NYSE:PFE) rose +1.01 Human Genome Sciences (NASDAQ:HGSI) grew +1.34%, Boston Scientific Corporation (NYSE:BSX) moved up +1.54%, Gilead Sciences, Inc. (NASDAQ:GILD) fell -2.39%, Merck & Co., Inc. (NYSE:MRK) which increased +0.96% and Johnson & Johnson (NYSE:JNJ) surged +1.08%.
Chemed Corporation (NYSE:CHE) stock’s trade at beginning with a price of $64.00 and throughout the trading session climbed at a high of $64.00 other than when day-trade ended the stock finally declined -7.21% to $59.24.
Shares price of CHE moved down from its 20 days moving average with -5.80% and remote negativley from 50 days moving average with -4.32%. CHE current year earnings per share experienced an addition with 5.89% while its current quarter performance remained 4.76%.
CHE had a trade volume of 1.05 million shares was higher as compared to average trading capacity of 173,153.00 shares.
CHE last month stock price volatility remained 2.12%. In its share capital CHE has 19.23 million outstanding shares among them 17.55 million shares have been floated in market exchange. CHE stock institutional ownership remained 91.10% while insider ownership included 2.36%.
The stock is ahead its 52 week low with 24.62% and lagging behind from its 52 week high price with -17.16%. Company’s beta coefficient included 0.40. Beta factors measures the amount of market risk associated with market trade.
DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! QuoteDaddy.com delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with QuoteDaddy.com! CLICK HERE TO START YOUR FREE 30-DAY TRIAL